Penington Institute
‘Overdose is an Australian problem’: Penington Institute
Access to lifesaving treatment, including naloxone and opioid replacement therapy “remains uneven”, as the number of overdose deaths hits a record high Findings from the 2026 edition of Australia’s Annual …
Prescriber deficit limiting access to medicinal cannabis
TGA data shows growth in medicinal cannabis approvals, but barriers to access remain Sales of medicinal cannabis products in 2024 are on track to double the number sold in 2023, …
Pharmacists can play ‘key role’ in reducing overdose numbers
Opioids and benzodiazepines are the most common drugs associated with unintentional drug-induced deaths in Australia, new leading report shows Overdose continues to be a leading cause of death for Australians …
Naloxone report calls for end to ‘onerous’ barriers
A new report from the Penington Institute has called for free take-home naloxone to be available from pharmacies and other sites, as Health Minister announces new product A report released …
Prescription overdose deaths continue to climb
Organisations are again calling for real-time prescription monitoring across the nation to combat the alarming figures The Penington Institute has released Australia’s Annual Overdose Report 2016 and its findings reveal a …